 |
Our Model
ASLAN inlicenses preclinical candidate drugs
and takes them to proof-of-concept, leveraging high quality resources in
Asia, then offers them back to the originator or other pharma companies for
late phase global development.
|
 |
 |
Partnering
ASLAN is currently looking to inlicense
preclinical and early development compounds into our pipeline across a
variety of therapeutic areas
|
